The FOOTPATH study: protocol for a multicentre, participant- and assessor-blind, parallel group randomised clinical trial of foot orthoses for patellofemoral osteoarthritis
journal contributionposted on 2021-01-12, 22:42 authored by Natalie J Collins, Jade Tan, Hylton MenzHylton Menz, Trevor G Russell, Anne J Smith, Bill Vicenzino, Shannon MunteanuShannon Munteanu, Rana S Hinman, Terry P Haines, Harvi HartHarvi Hart, Brooke PattersonBrooke Patterson, Gearoid Cleary, Joel W Donnar, Liam R Maclachlan, Kay CrossleyKay Crossley
© Author(s) (or their employer(s)) 2019. Published by BMJ. Introduction Patellofemoral (PF) osteoarthritis (OA) is a common and burdensome subgroup of knee OA, with very little evidence for effective treatments. Prefabricated foot orthoses are an affordable and accessible intervention that have been shown to reduce PF pain in younger adults. Similarities between PF pain and PFOA, as well as our pilot work, suggest that foot orthoses may also be an effective intervention for PFOA. The primary objective of this study is to compare the 3 month efficacy of prefabricated foot orthoses and flat shoe inserts in people with PFOA, on knee pain severity. Methods and analysis The FOOTPATH Study (FOot OrThoses for PAtellofemoral osteoarTHritis) is a multicentre, randomised, participant- and assessor-blinded superiority trial with two parallel groups, a 3 month observation period (pre-randomisation) and 12 month follow-up. 160 participants with a clinical diagnosis of PFOA will be recruited from three sites in Australia, and randomised to one of two groups (prefabricated foot orthoses or flat shoe inserts). The primary outcome is worst knee pain severity during a self-nominated aggravating activity in the previous week (100 mm visual analogue scale) at 3 months, with a secondary endpoint at 12 months. Secondary outcomes include global rating of change, symptoms, function, health-related quality of life, kinesiophobia, self-efficacy and use of co-interventions for knee pain. Blinded, intention-to-treat analyses of primary and secondary patient-reported outcomes will be performed, as well as economic analyses. Ethics and dissemination Ethical approval has been granted by La Trobe University's Human Ethics Committee and The University of Queensland's Medical Research Ethics Committee. Study outcomes will be disseminated via peer-reviewed journals, conference presentations targeting a range of healthcare disciplines and an open access website with clinician resources. Trial registration number ANZCTRN12617000385347; Pre-results.
This work is supported by the National Health and Medical Research Council (Australia) (ID: 1106852; 2016-2019). NJC previously held a University of Queensland Postdoctoral Research Fellowship (2015-2017). HBM is currently a National Health and Medical Research Council Senior Research Fellow (ID: 1135995). RSH currently holds an Australian Research Council (ARC) Future Fellowship (ID: FT130100175). Vasyli Medical (Labrador, Australia) will provide the foot orthoses, flat inserts and sandals.
Rights StatementThe Author reserves all moral rights over the deposited text and must be credited if any re-use occurs. Documents deposited in OPAL are the Open Access versions of outputs published elsewhere. Changes resulting from the publishing process may therefore not be reflected in this document. The final published version may be obtained via the publisher’s DOI. Please note that additional copyright and access restrictions may apply to the published version.
Science & TechnologyLife Sciences & BiomedicineMedicine, General & InternalGeneral & Internal MedicineKNEE OSTEOARTHRITISOUTCOME MEASURESJOINT OSTEOARTHRITISCONSENSUS STATEMENTPAINPEOPLERECOMMENDATIONSQUESTIONNAIREEFFICACYEXERCISEOsteoarthritis, KneePain MeasurementDouble-Blind MethodAustraliaTasmaniaMulticenter Studies as TopicRandomized Controlled Trials as TopicFoot OrthosesPatient Reported Outcome Measuresclinical trialskneerheumatology